» Articles » PMID: 15721354

Pim Kinases Are Upregulated During Epstein-Barr Virus Infection and Enhance EBNA2 Activity

Overview
Journal Virology
Specialty Microbiology
Date 2005 Feb 22
PMID 15721354
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Latent Epstein-Barr virus (EBV) infection is strongly associated with B-cell proliferative diseases such as Burkitt's lymphoma. Here we show that the oncogenic serine/threonine kinases Pim-1 and Pim-2 enhance the activity of the viral transcriptional activator EBNA2. During EBV infection of primary B-lymphocytes, the mRNA expression levels of pim genes, especially of pim-2, are upregulated and remain elevated in latently infected B-cell lines. Thus, EBV-induced upregulation of Pim kinases and Pim-stimulated EBNA2 transcriptional activity may contribute to the ability of EBV to immortalize B-cells and predispose them to malignant growth.

Citing Articles

Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics.

Lai L, Chen X, Tian G, Liang R, Chen X, Qin Y Cancer Control. 2022; 29:10732748221106268.

PMID: 35844176 PMC: 9290152. DOI: 10.1177/10732748221106268.


Targeting Host PIM Protein Kinases Reduces Mayaro Virus Replication.

Sugasti-Salazar M, Campos D, Valdes-Torres P, Galan-Jurado P, Gonzalez-Santamaria J Viruses. 2022; 14(2).

PMID: 35216015 PMC: 8878588. DOI: 10.3390/v14020422.


Feedback Loop Regulation between Pim Kinases and Tax Keeps Human T-Cell Leukemia Virus Type 1 Viral Replication in Check.

Bellon M, Nicot C J Virol. 2021; 96(3):e0196021.

PMID: 34818069 PMC: 8826812. DOI: 10.1128/JVI.01960-21.


The emerging regulatory roles of noncoding RNAs in immune function of fish: MicroRNAs versus long noncoding RNAs.

Abo-Al-Ela H Mol Genet Genomics. 2021; 296(4):765-781.

PMID: 33904988 DOI: 10.1007/s00438-021-01786-x.


PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells.

Cervantes-Gomez F, Stellrecht C, Ayres M, Keating M, Wierda W, Gandhi V Oncotarget. 2019; 10(29):2793-2809.

PMID: 31073371 PMC: 6497463. DOI: 10.18632/oncotarget.26876.